Log In
BCIQ
Print this Print this
 

NOV110102

  Manage Alerts
Collapse Summary General Information
Company National OncoVenture
Description mAb targeting DLK1
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today